Merit Medical Systems, Inc. (MMSI) fair value analysis
Nasdaq · Updated 2026-10-19
MMSI price how computed
Forward Fair Value verdict
UndervaluedMMSI is trading at a 10–25% discount to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $89.20
- Sector
- Healthcare
- 12-month range
- $60.31–$93.18
- Market cap
- $5.33B
- From 52-week high
- -4.3%
- Shares outstanding
- 59.7M
- Rank in Healthcare by discount to fair value
- #30 of 108
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
Merit Medical Systems, Inc. is a medical device company that designs, manufactures, and distributes cardiovascular and oncology medical devices. The company operates globally with manufacturing and distribution facilities across multiple continents serving hospitals, clinics, and healthcare providers worldwide.
MMSI currently ranks #30 of 108 Healthcare stocks by discount to fair value. It has screened as Undervalued for 14 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $5.33B
- P/E (trailing)
- 22x
- Revenue (TTM)
- $1.58B
- Net margin
- 9.2%
- EPS (TTM)
- $3.99
- Gross margin
- 51.4%
- Debt / equity
- 0.49
- Revenue growth (3-yr avg)
- 11.0%
- Shares outstanding
- 59.7M
Derived indicators how computed
- Quality grade
- A
- Margin trend
- Expanding
- 52-week position
- The top quarter of its range
- DCF cross-check
- Overvalued
Technicals how computed
- RSI (14-day)
- 60 · neutral
- 50-day average
- $88.29
- 200-day average
- $76.72
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Earnings how computed
- Next earnings report
- 2026-10-29 (post-market)
- Last 8 quarters vs consensus
- 8 beat, 0 missed
- Quarter by quarter
- 2026-06 ▲ beat (+28.2%)
2026-03 ▲ beat (+13.3%)
2025-12 ▲ beat (+9.5%)
2025-09 ▲ beat (+10.8%)
2025-06 ▲ beat (+18.8%)
2025-03 ▲ beat (+14.7%)
2024-12 ▲ beat (+12.0%)
2024-09 ▲ beat (+7.5%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 9 buy · 2 hold · 0 sell (11 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $102
- Target vs last price
- +14.3%
What our data shows for MMSI
- Our model validated 17 trailing price-to-earnings windows for MMSI, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $60.31–$93.18.
- The 14-day relative strength index sits at a neutral 60.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MMSI
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
Recent MMSI news
TickrTrends' derived news-sentiment signal for MMSI is currently leaning positive, computed from recent coverage.
- Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026 (manilatimes.net, 2026-10-06)
TickrTrends take: Merit Medical Systems is scheduled to report its third quarter 2026 financial results on October 29, 2026, providing an opportunity to assess whether the company's operational performance aligns with TickrTrends' current undervalued assessment. For investors focused on valuation, the quarterly earnings announcement will offer concrete data on revenue trends, profitability, and cash flow generation in the healthcare sector that can either support or challenge the undervaluation thesis. The results will be particularly relevant for determining whether Merit Medical's fundamentals justify its current market pricing relative to peers in its industry. - MMSI Reiterated by Needham -- Price Target Maintained at $101 (gurufocus.com, 2026-09-29)
TickrTrends take: Needham's maintained price target for MMSI suggests analyst confidence in the company's fundamental trajectory, which aligns with TickrTrends' current assessment that the stock is undervalued. For a valuation-focused reader in the healthcare sector, the reiteration is noteworthy as it indicates the analyst sees sustainable value at current levels without requiring significant upward target revisions. Observers should monitor whether the company's execution on its healthcare initiatives closes any gap between current trading levels and analyst price targets over coming quarters. - Merit Medical to Participate in Upcoming Investors Conferences in September (manilatimes.net, 2026-09-04)
TickrTrends take: Merit Medical Systems announced participation in investor conferences scheduled for September, which typically provide opportunities for management to discuss operational performance and strategic direction with institutional investors. Given TickrTrends' current assessment that MMSI trades as undervalued, such conference appearances may offer insight into whether management commentary addresses the factors contributing to the current valuation discount in the Healthcare sector. Investors focused on valuation metrics should monitor whether these conferences yield guidance or updates that could affect the company's fundamental outlook relative to its current market price.
What people are saying
Follow the MMSI conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — # MMSI Weekly Indicator Summary TickrTrends' derived indicators for MMSI showed a significant shift this week as the 50/200-day trend state transitioned from mixed to uptrend. This technical improvement reflects strengthening momentum in the stock's price movement relative to its longer-term average. With a current valuation verdict of undervalued, the stock presents a technical profile that combines improving trend dynamics with attractive pricing metrics in the healthcare sector.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — TickrTrends' derived indicators for MMSI show a shift in the 50/200-day trend state from uptrend to mixed during the past week. Despite this change in trend momentum, the stock maintains an undervalued valuation verdict. The transition from a clear uptrend to a mixed state suggests reduced directional conviction in the near-term price movement.
- 2026-09-28 — MMSI in the Healthcare sector moved from an oversold RSI zone to a neutral RSI zone this week according to TickrTrends' derived indicators. The stock maintains an undervalued verdict based on current valuation metrics. This shift in the RSI indicator suggests the stock has moved away from extreme selling pressure.
- 2026-09-21 — TickrTrends' derived indicators for MMSI in the Healthcare sector show a shift in momentum this week, with the Relative Strength Index moving from the neutral zone into oversold territory. This change suggests increased selling pressure in the stock. The current valuation assessment remains Undervalued.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is MMSI stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), MMSI is trading at a 10–25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is MMSI's TickrTrends verdict?
MMSI's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does MMSI compare to other Healthcare stocks?
MMSI ranks #30 of 108 Healthcare stocks in TickrTrends' coverage by discount to fair value.
Is MMSI overbought or oversold?
MMSI's 14-day RSI is in neutral territory - neither overbought nor oversold.
When does MMSI report earnings next?
MMSI's next earnings report is scheduled for 2026-10-29 (post-market), per the published earnings calendar.
Does MMSI usually beat earnings estimates?
Over its last 8 reported quarters MMSI beat the consensus estimate 8 times and missed 0 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about MMSI?
Of 11 analysts covering MMSI, 9 rate it a buy, 2 a hold and 0 a sell - buy-leaning, with a consensus price target of $102 (+14.3% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Healthcare
Head-to-head comparisons
MMSI vs ABT · MMSI vs AMPH · MMSI vs CI · MMSI vs DVA · MMSI vs EW